Fagron has been growing earnings at an average annual rate of 9.1%, while the Healthcare industry saw earnings growing at 4% annually. Revenues have been growing at an average rate of 12.1% per year. Fagron's return on equity is 16.5%, and it has net margins of 9.6%.
Key information
9.10%
Earnings growth rate
8.90%
EPS growth rate
Healthcare Industry Growth
8.50%
Revenue growth rate
12.12%
Return on equity
16.45%
Net Margin
9.56%
Next Earnings Update
30 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fagron makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:ARSU.F Revenue, expenses and earnings (EUR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Dec 25
952
91
240
0
30 Sep 25
935
88
239
0
30 Jun 25
919
86
237
0
31 Mar 25
895
83
230
0
31 Dec 24
872
81
223
0
30 Sep 24
846
79
214
0
30 Jun 24
821
78
205
0
31 Mar 24
792
74
196
0
31 Dec 23
763
71
187
0
30 Sep 23
745
69
181
0
30 Jun 23
727
67
175
0
31 Mar 23
705
69
166
0
31 Dec 22
684
70
158
0
30 Sep 22
655
70
149
0
30 Jun 22
626
69
140
0
31 Mar 22
600
65
136
0
31 Dec 21
574
61
133
0
30 Sep 21
564
58
131
0
30 Jun 21
554
55
129
0
31 Mar 21
555
57
127
0
31 Dec 20
556
60
125
0
30 Sep 20
557
60
125
0
30 Jun 20
558
60
126
0
31 Mar 20
546
58
125
0
31 Dec 19
535
55
125
0
30 Jun 19
496
51
120
0
31 Mar 19
484
47
116
0
31 Dec 18
472
43
113
0
30 Jun 18
444
45
103
0
31 Mar 18
439
46
102
0
31 Dec 17
434
47
101
0
30 Sep 17
433
16
101
0
30 Jun 17
432
-14
101
0
31 Mar 17
428
-15
100
0
31 Dec 16
422
-19
97
0
30 Sep 16
421
-25
99
0
30 Jun 16
421
-31
101
0
31 Mar 16
474
-203
124
0
31 Dec 15
428
-25
104
0
30 Sep 15
441
8
105
0
30 Jun 15
455
41
106
0
Quality Earnings: ARSU.F has high quality earnings.
Growing Profit Margin: ARSU.F's current net profit margins (9.6%) are higher than last year (9.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ARSU.F's earnings have grown by 9.1% per year over the past 5 years.
Accelerating Growth: ARSU.F's earnings growth over the past year (13%) exceeds its 5-year average (9.1% per year).
Earnings vs Industry: ARSU.F earnings growth over the past year (13%) did not outperform the Healthcare industry 17%.
Return on Equity
High ROE: ARSU.F's Return on Equity (16.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/27 10:02
End of Day Share Price
2026/04/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fagron NV is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.